Full text is available at the source.
Design and synthesis of novel xanthone-triazole derivatives as potential antidiabetic agents: α-Glucosidase inhibition and glucose uptake promotion
New xanthone-triazole compounds that may help diabetes by blocking sugar digestion and boosting glucose absorption
AI simplified
Abstract
Compound 5e demonstrated an IC value of 2.06 μM, making it the most potent α-glucosidase inhibitor identified.
- Most novel xanthone-triazole derivatives exhibited better α-glucosidase inhibitory activities than the parental compound and the positive control.
- Compounds 5e, 5g, 5h, 6c, 6d, 6g, and 6h were found to be noncompetitive inhibitors of α-glucosidase.
- Molecular docking studies indicated that these compounds bind to allosteric sites away from the active site.
- Compounds 5e, 6a, 6c, and 7g significantly promoted glucose uptake in HepG2 cells.
- Most compounds displayed low toxicity to the human normal hepatocyte cell line (LO2).
AI simplified